MADRIGAL PHARMACEUTICALS, INC. (MDGL) Most Active Options

The 25 most actively traded MADRIGAL PHARMACEUTICALS, INC. (MDGL) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$551.22
52-week range
$289.89 – $612.00
ATM IV (30d)
41.6%
IV rank
54 / 100
Moderate
Expected move
±$31.72 (±5.8%)
Put/call OI
0.40
Call-heavy
Max pain
$500
↓ 9.3% below close
Next earnings
Aug 5, 2026

Most Active MDGL Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
MDGL $500 call Mar 19, 2027 252d $127.00 59.4% 64 0.67 263 50 12.4× avg
MDGL $290 put Oct 16, 2026 98d $1.97 68.0% 18 -0.03 0 48 41.5× avg
MDGL $600 call Aug 21, 2026 42d $23.20 56.2% 62 0.32 20 20 3.6× avg
MDGL $520 call Jul 17, 2026 7d $21.90 43.1% 10 0.72 18 15 7.5× avg
MDGL $480 call Oct 16, 2026 98d $92.00 55.2% 39 0.72 1 10 2.5× avg
MDGL $530 put Jan 15, 2027 189d $75.20 54.4% 41 -0.39 0 6 70.6× avg
MDGL $550 put Jul 17, 2026 7d $17.10 43.3% 0 -0.64 11 5 4.4× avg
MDGL $610 call Oct 16, 2026 98d $30.30 51.1% 25 0.38 3 5 8.4× avg
MDGL $540 call Jul 17, 2026 7d $11.95 41.6% 19 0.47 36 5 2.1× avg
MDGL $550 call Jul 17, 2026 7d $7.90 42.1% 25 0.35 184 5 2.1× avg
MDGL $530 call Jul 17, 2026 7d $15.80 44.2% 50 0.60 18 5 2.1× avg
MDGL $500 call Jul 17, 2026 7d $36.80 51.1% 46 0.85 340 4 2.0× avg
MDGL $510 call Jul 17, 2026 7d $27.60 46.8% 27 0.80 24 4 2.0× avg
MDGL $530 put Jul 17, 2026 7d $10.00 45.7% 40 -0.40 41 3 2.6× avg
MDGL $540 call Aug 21, 2026 42d $40.50 58.3% 56 0.54 9 3 3.7× avg
MDGL $540 call Dec 18, 2026 161d $77.00 56.0% 52 0.58 190 3 2.1× avg
MDGL $650 call Aug 21, 2026 42d $9.98 56.5% 37 0.19 5 3 0.7× avg
MDGL $640 call Aug 21, 2026 42d $11.48 57.5% 68 0.22 7 3 0.5× avg
MDGL $450 call Jul 17, 2026 7d $85.90 66.6% 75 0.98 221 2 6.0× avg
MDGL $570 call Jul 17, 2026 7d $2.50 45.5% 57 0.18 2,019 2 1.1× avg
MDGL $680 call Jul 17, 2026 7d $0.65 103.8% 27 0.06 5 2 0.3× avg
MDGL $510 call Oct 16, 2026 98d $71.10 54.0% 32 0.64 4 2 0.5× avg
MDGL $300 put Oct 16, 2026 98d $2.80 65.1% 13 -0.03 0 2 1.7× avg
MDGL $510 put Jul 17, 2026 7d $5.29 50.6% 21 -0.22 1,408 1 1.1× avg
MDGL $500 put Jul 17, 2026 7d $3.00 51.9% 23 -0.15 170 1 1.1× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active MDGL contract today is the $500 call expiring in 252 days, with 50 contracts traded. Calls dominate the most-active list (18 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on MDGL for free

Build multi-leg MDGL strategies, visualize payoffs, and scan the full US options universe with OptiView.

MDGL Options FAQ

Which MDGL option contract is most active today?

The most traded MDGL contract is the $500 call expiring Mar 19, 2027, with 50 contracts traded as of Jul 10, 2026.

How does OptiView rank the most active MDGL options?

The table lists the 25 MDGL contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.